International AIDS Society Conference

July 17-20, 2011 - Rome, Italy

Back IAS 2011

IAS 2011: AIDS is at a Scientific Watershed [VIDEO]

Speaking Sunday at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opening plenary and press conference, IAS President and conference co-chair Elly Katabira underlined recent advances in biomedical prevention, including findings from the iPrEx, Partners PrEP and TDF2, and HPTN 052 trials showing that pre-exposure prophylaxis and early treatment can reduce HIV transmission.  alt

Read more:

IAS 2011: Expand Treatment for Prevention, Experts Urge

Experts from the International AIDS Society (IAS) and UNAIDS expressed support for an editorial comment by Julio Montaner in the forthcoming issue of The Lancet, calling for expansion of early antiretroviral therapy as one strategy in a comprehensive approach to prevention of HIV infection.alt

Read more:

IAS 2011 Will Explore Diverse Aspects of HIV/AIDS

The 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) will take place July 17-20 in Rome. Organizers have accepted more than 1000 abstracts exploring topics ranging from biomedical prevention to new strategies towards a cure.

HIVandHepatitis.com will be onsite providing daily reports and videos covering highlights of the meeting.

Onsite registration will be possible starting July 16. For more information about the conference, see http://www.ias2011.org. alt

Read more:

IAS 2011: New Studies Add Evidence that PrEP Reduces HIV Infection Risk

Pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine (the drugs in Truvada) lowers the risk of HIV transmission among heterosexuals, according to 2 African studies to be presented next week at the 6th International AIDS Society Conference of HIV Pathogenesis, Treatment and Prevention (IAS 2011).

Read more: